Thanks for logging in.

You can now click/tap WATCH to start the live stream.

Thanks for logging in.

You can now click/tap LISTEN to start the live stream.

Thanks for logging in.

You can now click/tap LATEST NEWS to start the live stream.

LISTEN
Watch
on air now

Create a 3AW account today!

You can now log in once to listen live, watch live, join competitions, enjoy exclusive 3AW content and other benefits.


Joining is free and easy.

You will soon need to register to keep streaming 3AW online. Register an account or skip for now to do it later.

Advertisement
Advertisement
Advertisement

The fund manager set on making biotech investment the way of the future

Brooke Corte
Article image for The fund manager set on making biotech investment the way of the future

Biotech companies are at the centre of future success, with one investment group setting its sights on the industry.

These are the companies working to help us live longer, healthier lives by creating cutting edge treatments for devastating diseases.

Merchant Funds’ new Biotech fund focuses on emerging Australian biotech, medical and health sciences companies, giving retail investors the chance to own a piece of this exciting growth industry.

CEO Andrew Chapman joins Brooke Corte to explain the exciting opportunities.

Press PLAY below to hear more from Merchant Group

Andrew Chapman appeared on Money News thanksĀ to Merchant Group
Brooke Corte
Advertisement